您的位置: 首页 > 农业专利 > 详情页

Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
专利权人:
Sven Ole Warnaar
发明人:
Sven Ole Warnaar,Stefan Ullrich
申请号:
US12559839
公开号:
US08828381B2
申请日:
2009.09.15
申请国别(地区):
US
年份:
2014
代理人:
摘要:
A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN). The improved treatment method is characterized in a significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone, resulting in a positive therapeutic response with respect to that observed with single anti-tumor agents alone.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充